2013-04203. National Cancer Institute; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the Start Printed Page 12766provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis Panel; National Cancer Institute Provocative Questions B.

    Date: March 21-22, 2013.

    Time: 4:00 p.m. to 5:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Bethesda North Marriott Hotel & Conference Center 5701 Marinelli Road Bethesda, MD 20852.

    Contact Person: Michael B. Small, Ph.D. Scientific Review Officer Division of Extramural Activities National Cancer Institute National Institutes of Health 6116 Executive Blvd., Room 8127 Bethesda, MD 20892-8328 301-402-0996 smallm@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel; Training and Education.

    Date: March 26, 2013.

    Time: 1:00 p.m. to 3:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health 6116 Executive Boulevard Room 707 Rockville, MD 20852 (Telephone Conference Call).

    Contact Person: Timothy C. Meeker, MD, Ph.D. Scientific Review Officer Resources and Training Review Branch Division of Extramural Activities National Cancer Institute, NIH 6116 Executive Boulevard, Room 8103 Bethesda, MD 20892 301-594-1279 meekert@mail.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

    Start Signature

    Dated: February 19, 2013.

    Melanie J. Gray,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2013-04203 Filed 2-22-13; 8:45 am]

    BILLING CODE 4140-01-P